Cargando…
Comparison of (99m)Tc-sestamibi and doxorubicin to monitor inhibition of P-glycoprotein function
P-glycoprotein (Pgp) overexpression is a well-recognized factor in resistance to chemotherapy. Doxorubicin flow cytometry is used to monitor Pgp function in haematological specimens and biopsies from other cancers, and radionuclide imaging with sestamibi has recently shown promise for non-invasive m...
Autores principales: | Muzzammil, T, Moore, M J, Hedley, D, Ballinger, J R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363739/ https://www.ncbi.nlm.nih.gov/pubmed/11161402 http://dx.doi.org/10.1054/bjoc.2000.1621 |
Ejemplares similares
-
Comparison of (99m)Tc-Tetrofosmin and (99m)Tc-Sestamibi Uptake in Glioma Cell Lines: The Role of P-Glycoprotein Expression
por: Alexiou, George A., et al.
Publicado: (2014) -
99mTc-sestamibi is a substrate for P-glycoprotein and the multidrug resistance-associated protein.
por: Hendrikse, N. H., et al.
Publicado: (1998) -
Comparison of Tc-99m maraciclatide and Tc-99m sestamibi molecular breast imaging in patients with suspected breast cancer
por: O’Connor, Michael K., et al.
Publicado: (2017) -
Diagnostic accuracy of [(99m)Tc]Tc-Sestamibi in the assessment of thyroid nodules
por: Yordanova, Anna, et al.
Publicado: (2017) -
Use of Cinacalcet and (99m)Tc-sestamibi Imaging During Pregnancy
por: Rubin, Mishaela R., et al.
Publicado: (2017)